Please login to the form below

Not currently logged in
Email:
Password:

Donald Trump

This page shows the latest Donald Trump news and features for those working in and with pharma, biotech and healthcare.

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

patients who were given the drug – which President Donald Trump famously says he has been taking prophylactically to ward off coronavirus infection.

Latest news

More from news
Approximately 7 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus

  • The rise of CEO activism The rise of CEO activism

    In 2018, Merck CEO Kenneth Frazier famously resigned from Donald Trump’s business advisory council after Trump failed to condemn neo-Nazi protests in Charlottesville. ... Frazier took to Twitter to make his stand and, within an hour, Trump responded by

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    and Donald Trump’s election campaign, or Christopher Wylie, the ‘whistleblower’ and data scientist whose idea at the age of 24 had led to the foundation of Cambridge Analytica. ... Evidence presented to the House of Commons Committee showed that

  • Pharma deals continue to slide Pharma deals continue to slide

    Little did US electors know what would be the effect on the US biopharma industry and its deals when they elected Donald Trump. ... Similarly, the Euro is now around 10% stronger against the dollar since President Trump was inaugurated.

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics